Lee Roth | IR |
Liz Barrett | President and CEO |
Mark Schoenberg | Chief Medical Officer |
Jeff Bova | Chief Commercial Officer |
Molly Henderson | CFO |
Chris Howerton | Jefferies |
Paul Choi | Goldman Sachs |
Matt Kaplan | Ladenburg Thalmann |
Leland Gershell | Oppenheimer |
Good morning, ladies and gentlemen, and thank you for standing by. And welcome to UroGen Pharma's Third Quarter 2021 Financial Results and Business Update Conference Call. It is now my pleasure to turn the call over to Lee Roth, Investor Relations for UroGen Pharma. Please go ahead.
Thank you, Jonathan, Good morning, everyone and once again welcome to the UroGen Pharma's third quarter 2021 financial results and business update conference call.